1-5 of 5
Derrick Kaufman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glofitamab Induces High Response Rates and Durable Remissions in Patients (Pts) with Heavily Pretreated Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL), Including Those with a Poor Prognosis: Subgroup Results from a Phase I/II Study

Tycel J. Phillips, Marek Trněný, Carmelo Carlo-Stella, Jan Maciej Zaucha, Tomasz Wrobel, Fritz Offner, Michael J. Dickinson, Monica Tani, Michael Crump, Nancy L. Bartlett, Joaquín Martínez-Lopez, Paolo Corradini, Estefania Mulvihill, Alessia Bottos, Derrick Kaufman, James Relf, Fabiola Bene Tchaleu, Alexandra Bazeos, Linda Lundberg, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 1631.
https://doi.org/10.1182/blood-2024-200018
Published: 2024
Journal Articles

SKYGLO: A Global Phase III Randomized Study Evaluating Glofitamab Plus Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients with Large B-Cell Lymphoma (LBCL)

Ranjana H. Advani, Michael J. Dickinson, Christopher P. Fox, Brad Kahl, Alex F. Herrera, Georg Lenz, Yuqin Song, Rong Tao, Qingqing Cai, Tae Min Kim, Michelle Doral, Derrick Kaufman, Leonardo Roque Pereira, Aurelien Berthier, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 1718.1.
https://doi.org/10.1182/blood-2024-194000
Published: 2024
Journal Articles

Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

Clinical Trials & Observations
Laurie H. Sehn, Nancy L. Bartlett, Matthew J. Matasar, Stephen J. Schuster, Sarit E. Assouline, Pratyush Giri, John Kuruvilla, Mazyar Shadman, Chan Y Cheah, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta J. Nastoupil, Michael C. Wei, Shen Yin, Iris To, Derrick Kaufman, Antonia Kwan, Elicia Penuel, Christopher R. Bolen, Lihua Elizabeth Budde
Journal: Blood
Blood blood.2024025454.
https://doi.org/10.1182/blood.2024025454
Published: 2024
Includes: Supplemental data
Journal Articles

Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase II Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume

Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Lorenzo Falchi, Emmanuel Bachy, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquin Martinez-Lopez, Nancy L. Bartlett, Antonio Salar, Joshua Brody, Sirpa Leppä, Pauline Baumlin, Estefania Mulvihill, James Relf, Yuying Xie, Derrick Kaufman, Linda Lundberg, Michael Dickinson
Journal: Blood
Blood (2023) 142 (Supplement 1): 433.
https://doi.org/10.1182/blood-2023-173951
Published: 2023
Journal Articles

Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase Ib Study

Max S. Topp, Monica Tani, Michael Dickinson, Nilanjan Ghosh, Armando Santoro, Antonio Pinto, Francesc Bosch, Christopher P. Fox, Armando Lopez-Guillermo, Thomas Gastinne, Andreas Viardot, William Townsend, Naseer Qayum, Martin Barrett, Derrick Kaufman, Chun Wu, Ronald McCord, Pauline Baumlin, Patrick Kimes, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 3085.
https://doi.org/10.1182/blood-2023-174081
Published: 2023